Teriparatide in postmenopausal women with osteoporosis and mild or moderate renal impairment

Paul D. Miller(University of Colorado Health), John H. Krege(Eli Lilly (United States)), P. Chen(Eli Lilly (United States)), Elliott N. Schwartz, Derek Misurski(Eli Lilly (United States))
Osteoporosis International
September 29, 2006
10.1007/s00198-006-0189-8
Cited by 235

Related Papers

Generation and reproductive phenotypes of mice lacking estrogen receptor β
|Proceedings of the National Academy of Sciences|1998|1.7k
Elevated blood pressures in mice lacking endothelial nitric oxide synthase
|Proceedings of the National Academy of Sciences|1996|903
Male–female differences in fertility and blood pressure in ACE-deficient mice
|Nature|1995|647
Genetic Decreases in Atrial Natriuretic Peptide and Salt-Sensitive Hypertension
|Science|1995|646
Genetic control of blood pressure and the angiotensinogen locus.
|Proceedings of the National Academy of Sciences|1995|642